An amendment numbered 9 printed in Part A of House Report 114-551 to require the Inter-Agency Task Force, as part of its duties to review and update best practices for pain management strategies, to also take into consideration the coordination of information collected from State prescription drug monitoring programs for the purpose of preventing the diversion of pain medication.